The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated efficacy and safety results from the phase 2 study of serplulimab, a novel anti-PD-1 antibody, in patients with previously treated unresectable or metastatic microsatellite instability-high or mismatch repair-deficient solid tumors.
 
Jin Li
No Relationships to Disclose
 
Shukui Qin
No Relationships to Disclose
 
Haijun Zhong
No Relationships to Disclose
 
Chuan Jin
No Relationships to Disclose
 
Lili Chen
No Relationships to Disclose
 
Xianglin Yuan
No Relationships to Disclose
 
Qingxia Fan
No Relationships to Disclose
 
Kehe Chen
No Relationships to Disclose
 
Peiguo Cao
No Relationships to Disclose
 
Jianjun Xiao
No Relationships to Disclose
 
Da Jiang
No Relationships to Disclose
 
Tao Zhang
No Relationships to Disclose
 
Hongyu Zhang
No Relationships to Disclose
 
Xicheng Wang
No Relationships to Disclose
 
Wei Wang
No Relationships to Disclose
 
Lin Han
Employment - Shanghai Henlius Biotech
 
Qingyu Wang
Employment - Shanghai Henlius Biotech
Leadership - Shanghai Henlius Biotech
 
Jun Zhu
Employment - Shanghai Henlius Biotech
Leadership - Shanghai Henlius Biotech